Puerarin
- Generic Name
- Puerarin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H20O9
- CAS Number
- 3681-99-0
- Unique Ingredient Identifier
- Z9W8997416
- Background
Puerarin has been investigated for the treatment of Alcohol Abuse.
- Indication
用于辅助治疗冠心病、心绞痛、心肌梗死，视网膜动、静脉阻塞、突发性耳聋、血性脑血管病、小儿病毒性心肌炎、糖尿病等。眼科用于原发性开角型青光眼、高眼压症、原发性闭角型青光眼、继发性青光眼。
- Associated Conditions
- -
- Associated Therapies
- -
Effect of Puerarin on Heart Health in Men
Phase 2
Completed
- Conditions
- Cardiovascular Disease Risk Factors
- Interventions
- Drug: PuerarinDrug: Placebo
- First Posted Date
- 2018-09-18
- Last Posted Date
- 2021-04-29
- Lead Sponsor
- The University of Hong Kong
- Target Recruit Count
- 217
- Registration Number
- NCT03676296
- Locations
- 🇨🇳
The University of Hong Kong, Hong Kong, China
Alveolar Cleft Grafting Using Two Different Alloplastic Grafts
Phase 2
- Conditions
- Alveolar Cleft Grafting
- Interventions
- First Posted Date
- 2017-01-11
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 20
- Registration Number
- NCT03016793
- Locations
- 🇪🇬
Mohamad hamed Maklad, Suez, Egypt
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath